CTOs on the Move

Dent Neurologic Institute

www.dentinstitute.com

 
The DENT Neurologic Institute is among the largest, most comprehensive neurology practices in the United States. We are focused on providing superior clinical care, advanced diagnostic services, clinical research, and education.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

SERVICES Hospital Pharmacy Management and Consulting

SERVICES Hospital Pharmacy Management and Consulting is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ATLANTA WOMENS SPECIALIST PC

ATLANTA WOMENS SPECIALIST PC is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biozyme

Biozyme is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kelyniam

Our mission at Kelyniam is to apply 3D printing and rapid prototyping technology to create innovative medical products that improve the lives of physicians and their patients. 

Windtree Therapeutics

Windtree Therapeutics, Inc. is advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in moments of crisis. Using new clinical approaches, Windtree is developing a multi-asset franchise anchored around compounds with an ability to activate SERCA2a, with lead candidate istaroxime being developed as a first-in-class treatment for acute heart failure and early cardiogenic shock in heart failure. Windtree has also focused on developing AEROSURF® as a non-invasive surfactant treatment for premature infants with respiratory distress syndrome, and is facilitating transfer of clinical development of AEROSURF® to its licensee in Asia, Lee`s HK, while Windtree evaluates other uses for its synthetic KL4 surfactant for the treatment of acute pulmonary conditions including lung injury due to viral, chemical and radiation induced insults. Also, in its portfolio is rostafuroxin, a novel precision drug product targeting hypertensive patients with certain genetic profiles.